Your research can change the world
More on impact ›
Antivirals and Vaccines publishes high-quality fundamental, translational, pre-clinical, and clinical research across all aspects of antiviral chemotherapy and viral vaccines.
The 'Antivirals and Vaccines' section of the journal Frontiers in Virology publishes high-quality fundamental, translational, pre-clinical and clinical research across all aspects of antiviral chemotherapy and viral vaccines, highly important and relevant branches of human and animal virology that are essential to manage viral diseases in humans and animals. Both antivirals and vaccines have played a main role through history and are considered major advancements for public health. They are now essential to combating the currently ongoing COVID-19 pandemic and they will be crucial to facing and eradicating future viral pandemics. Antivirals and vaccines have a foremost and undeniable role in virology and this section will covered significant advances in areas including, but are not limited to:
• Human and animal vaccines & antivirals
• Vaccine research and development
• Novel vaccine design and technology
• Vaccine vectors, adjuvants, immunomodulators and delivery systems
• Prophylactic vaccines & therapeutic vaccines
• Immune responses to vaccines
• Antiviral research and development
• New viral targets, novel antivirals and their mode of action
• Drug-resistant and vaccine-resistant viruses
• Efficacy and safety of novel vaccines and antivirals
• Animal models and clinical trials
• Vaccine acceptance and vaccine hesitancy
The studies published in this section should provide insights into the discovery, mode of action, clinical development, use of vaccines and antiviral agents, and prevention and/or treatment of viral diseases in humans and animals. Reports dealing with effects of viruses on the immune system and viral immunopathogenesis do not fall within the scope of this section and should be submitted to more specialized sections of this journal or to our sister Journal, Frontiers in Immunology. We encourage publication of experimental results accompanied by the full experimental details so that the results can be reproduced. We do not publish a medical hypothesis without experimental evidence.
Indexed in: CLOCKSS, CrossRef, DOAJ, Google Scholar, OpenAIRE
PMCID: NA
Antivirals and Vaccines welcomes submissions of the following article types: Brief Research Report, Case Report, Classification, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Antivirals and Vaccines, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41 (0)21 510 17 00
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41 (0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact virology.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact virology@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org